Lactulose and Other Medications for Hepatic Encephalopathy

Oral Lactulose Dosing

The American Association for the Study of Liver Diseases recommends initial dosing of lactulose at 30-45 mL (20-30 g) every 1-2 hours orally until at least 2 soft bowel movements are produced daily, then titrated to 30-45 mL 3-4 times daily to maintain 2-3 soft stools per day 1
Maintenance therapy with lactulose should be titrated to achieve 2-3 soft stools per day, with a dosage of 30-45 mL (20-30 g) 3-4 times daily 2, 3

For patients with severe hepatic encephalopathy, rectal administration of lactulose may be necessary, with a mixture of 300 mL lactulose with 700 mL water or physiologic saline 2, 1

Rifaximin is effective as an adjunct to lactulose or alternative in patients who don't respond to lactulose, with a dosage of 400 mg three times daily or 550 mg twice daily, and has been shown to improve recovery rates when combined with lactulose 2
L-Ornithine-L-Aspartate (LOLA) can be used to lower plasma ammonia concentrations, with an intravenous dosage of 30 g/day, and has been shown to improve hepatic encephalopathy grade when combined with lactulose 2
Branched-Chain Amino Acids (BCAAs) can be used as an ancillary pharmacological option, with an oral dosage of 0.25 g/kg/day, and have been shown to inhibit proteolysis and decrease influx of toxic materials via blood-brain barrier 2, 3
Albumin can be used to improve recovery rate, with an intravenous dosage of 1.5 g/kg/day until clinical improvement or for maximum 10 days, and has been shown to improve recovery rate when combined with lactulose 2
Polyethylene Glycol (PEG) can be used as a substitute for non-absorbable disaccharides, with a dosage of 4 liters orally over 4 hours via oral administration or nasogastric tube, and has been shown to be superior to lactulose in terms of clinical improvement over a 24-hour period 2

Overuse of lactulose can lead to dehydration, hypernatremia, perianal skin irritation, and may paradoxically precipitate hepatic encephalopathy, with a recommended dosage of 30-45 mL (20-30 g) 3-4 times daily 3, 1
Neomycin and metronidazole are not recommended due to side effects, such as intestinal malabsorption, nephrotoxicity, ototoxicity for neomycin and peripheral neuropathy for metronidazole 2

Maintenance therapy should continue indefinitely in patients with cirrhosis who have experienced hepatic encephalopathy, as this is a chronic condition requiring ongoing prophylaxis 4
The standard maintenance regimen is 30-45 mL (20-30 g) administered 3-4 times daily, titrated to achieve 2-3 soft stools per day 4
There is no time limit for lactulose use in hepatic encephalopathy—patients typically remain on therapy for life or until liver transplantation 4

Aggressive dosing (30-45 mL every 1-2 hours) continues until clinical improvement occurs, typically achieving at least 2 soft bowel movements daily 4
For severe cases requiring rectal administration, lactulose enemas (300 mL lactulose mixed with 700 mL water) are given 3-4 times daily until clinical improvement, then transitioned to oral maintenance therapy 4

Lactulose provides two essential functions in liver disease patients: treats constipation through osmotic laxative effects while simultaneously reducing ammonia absorption, which prevents hepatic encephalopathy—a major cause of morbidity and mortality in cirrhotic patients 5, 6
Soapy water enemas provide only mechanical evacuation without ammonia-lowering effects, missing the critical therapeutic opportunity to prevent encephalopathy 6

Mix 300 mL of lactulose with 700 mL of water or physiologic saline, and administer via rectal balloon catheter, retaining for 30-60 minutes 5
Repeat every 4-6 hours until clinical improvement occurs 5
Transition to oral lactulose (30-45 mL three to four times daily) once the patient can tolerate oral intake 5

Isotonic saline enemas are preferable in older adults due to potential adverse effects of sodium phosphate enemas in this age group 7
Monitor for dehydration, hypernatremia, and electrolyte disturbances, and watch for severe perianal skin irritation with prolonged use 6
Regular monitoring is essential in elderly patients on diuretics or cardiac glycosides due to risk of dehydration and electrolyte imbalances 7

Transition to oral lactulose maintenance at 30-45 mL (20-30 g) three to four times daily, titrated to achieve 2-3 soft stools per day 5
Consider adding rifaximin 550 mg twice daily if breakthrough encephalopathy occurs despite adequate lactulose dosing 5